CasLoc logo
All Cases PTAB Litigations UPC Oppositions

NOVO NORDISK INC. v. GLENMARK PHARMACEUTICALS LIMITED

3:17-cv-03462

Overview

Case Number 3:17-cv-03462
Filing Date 2017-05-11
Status Terminated
Termination Date 2018-01-22
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

GLENMARK PHARMACEUTICALS LIMITED NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

NOVO NORDISK INC. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Motion to Strike / Sanctions 1

Key Dispositive Motions & Rulings

Motion to Strike / Sanctions Pending / Under Review
COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LIMITED ( Filing and Admin fee $ 400 receipt number 0312-7834004), filed by NOVO ...
Entry #1 • 2017-05-11 Document →

Docket Entries

(35 total)
Motion to Strike / Sanctions Pending / Under Review

COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LIMITED ( Filing and Admin fee $ 400 receipt number 0312-7834004), filed by NOVO NORDISK INC., NOVO NORDISK HEALTHCARE AG. (Attachments: # 1 Exhibit A, # 2 Certification Pursuant to Local Civil Rule 11.2, # 3 Civil Cover Sheet)(mmh) (Entered: 05/19/2017)

Entry #1 • 2017-05-11
1

Corporate Disclosure Statement by NOVO NORDISK HEALTHCARE AG, NOVO NORDISK INC. identifying NOVO NORDISK US HOLDINGS, INC.; NOVO NORDISK A/S; NOVO NORDISK INVEST 1 A/S; NOVO NORDISK A/S as Corporate Parent/Affiliates. (mmh) (Entered: 05/19/2017)

Entry #2 • 2017-05-11
1

SUMMONS ISSUED as to GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LIMITED Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *Melissa M. Haneke* (mmh) (Entered: 05/19/2017)

Entry #3 • 2017-05-19
1

AO120 Patent/Trademark Form filed. (mmh) (Entered: 05/19/2017)

Entry #4 • 2017-05-19
1
Pleading / Complaint

Writ of Execution Returned Executed on 5/19/2017., WAIVER OF SERVICE Returned Executed by NOVO NORDISK INC., NOVO NORDISK HEALTHCARE AG. GLENMARK PHARMACEUTICALS LIMITED waiver sent on 5/19/2017, answer due 7/18/2017. (DELORENZI, DAVID) (Entered: 05/26/2017)

Entry #5 • 2017-05-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc